CDX

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-2.8M ExitQ1 2026 $2.8M -- $21.12
Ken GriffinCitadel Advisors $2.8M123.9k shares AddQ4 2025 $2.4M $22.27 $21.12

News

globenewswire.comCelldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meetingglobenewswire.comJun 14

defenseworld.netSimplify High Yield ETF (NYSEARCA:CDX) Short Interest Up 1,869.9% in Marchdefenseworld.netMar 25

Trade CDX

About Simplify High Yield ETF

The Simplify High Yield ETF (CDX) is engineered to generate substantial current income. It achieves this by primarily allocating its capital to high-yield bonds, while simultaneously deploying strategies to reduce inherent credit risk. CDX offers foundational exposure to the high-yield market, delivering appealing income streams, and is fortified by a diverse array of dynamic and effective credit hedging techniques. Its principal hedging mechanism is rooted in a Quality-Junk factor. Furthermore, the ETF opportunistically invests in CDX call options and equity put options, assessing opportunities based on advantageous cost-to-payout ratios.

IPO Date: Feb 17, 2022

Market Data

Open: $21.26
High: $21.31
Low: $21.17
Volume: 95.6K
Avg Volume: 150K
52W High: $23.38
52W Low: $21.02

Valuation

Market Cap: $408M
Dividend Yield: 1.76%

Financials

Financial statement snapshot is not available yet.

Events

DividendMay 26

$0.12